SB-656933

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Colitis, UlcerativePulmonary Disease, Chronic Obstructive

Phase 1

Repeat Dose Study in Male Healthy Volunteer Smokers

CompletedNCT00615576

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2008-03-26End: 2008-07-24Updated: 2017-08-08

Phase 2

Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis

TerminatedNCT00748410

GlaxoSmithKlineColitis, Ulcerative

Start: 2009-01-22End: 2009-12-12Updated: 2020-10-30